625 related articles for article (PubMed ID: 22472349)
21. CXCL12 enhances human neural progenitor cell survival through a CXCR7- and CXCR4-mediated endocytotic signaling pathway.
Zhu B; Xu D; Deng X; Chen Q; Huang Y; Peng H; Li Y; Jia B; Thoreson WB; Ding W; Ding J; Zhao L; Wang Y; Wavrin KL; Duan S; Zheng J
Stem Cells; 2012 Nov; 30(11):2571-83. PubMed ID: 22987307
[TBL] [Abstract][Full Text] [Related]
22. The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects.
Hattermann K; Held-Feindt J; Lucius R; Müerköster SS; Penfold ME; Schall TJ; Mentlein R
Cancer Res; 2010 Apr; 70(8):3299-308. PubMed ID: 20388803
[TBL] [Abstract][Full Text] [Related]
23. The expression of CXCR4, CXCL12 and CXCR7 in malignant pleural mesothelioma.
Li T; Li H; Wang Y; Harvard C; Tan JL; Au A; Xu Z; Jablons DM; You L
J Pathol; 2011 Mar; 223(4):519-30. PubMed ID: 21294125
[TBL] [Abstract][Full Text] [Related]
24. Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways.
Drury LJ; Ziarek JJ; Gravel S; Veldkamp CT; Takekoshi T; Hwang ST; Heveker N; Volkman BF; Dwinell MB
Proc Natl Acad Sci U S A; 2011 Oct; 108(43):17655-60. PubMed ID: 21990345
[TBL] [Abstract][Full Text] [Related]
25. CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells.
Ieranò C; Santagata S; Napolitano M; Guardia F; Grimaldi A; Antignani E; Botti G; Consales C; Riccio A; Nanayakkara M; Barone MV; Caraglia M; Scala S
Cell Death Dis; 2014 Jul; 5(7):e1310. PubMed ID: 24991762
[TBL] [Abstract][Full Text] [Related]
26. Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway.
Xu D; Li R; Wu J; Jiang L; Zhong HA
Curr Top Med Chem; 2016; 16(13):1441-51. PubMed ID: 26369824
[TBL] [Abstract][Full Text] [Related]
27. Effects of the chemokine CXCL12 and combined internalization of its receptors CXCR4 and CXCR7 in human MCF-7 breast cancer cells.
Hattermann K; Holzenburg E; Hans F; Lucius R; Held-Feindt J; Mentlein R
Cell Tissue Res; 2014 Jul; 357(1):253-66. PubMed ID: 24770893
[TBL] [Abstract][Full Text] [Related]
28. The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma.
McConnell AT; Ellis R; Pathy B; Plummer R; Lovat PE; O'Boyle G
Br J Dermatol; 2016 Dec; 175(6):1210-1220. PubMed ID: 27167239
[TBL] [Abstract][Full Text] [Related]
29. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
Khare T; Bissonnette M; Khare S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
[TBL] [Abstract][Full Text] [Related]
30. Proinflammatory CXCL12-CXCR4/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice.
Saha A; Ahn S; Blando J; Su F; Kolonin MG; DiGiovanni J
Cancer Res; 2017 Sep; 77(18):5158-5168. PubMed ID: 28687617
[TBL] [Abstract][Full Text] [Related]
31. The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation.
Salazar N; Muñoz D; Kallifatidis G; Singh RK; Jordà M; Lokeshwar BL
Mol Cancer; 2014 Aug; 13():198. PubMed ID: 25168820
[TBL] [Abstract][Full Text] [Related]
32. CXCR7 agonists inhibit the function of CXCL12 by down-regulation of CXCR4.
Uto-Konomi A; McKibben B; Wirtz J; Sato Y; Takano A; Nanki T; Suzuki S
Biochem Biophys Res Commun; 2013 Feb; 431(4):772-6. PubMed ID: 23333329
[TBL] [Abstract][Full Text] [Related]
33. CXCR4, but not CXCR7, discriminates metastatic behavior in non-small cell lung cancer cells.
Choi YH; Burdick MD; Strieter BA; Mehrad B; Strieter RM
Mol Cancer Res; 2014 Jan; 12(1):38-47. PubMed ID: 24025971
[TBL] [Abstract][Full Text] [Related]
34. CXCR7 prevents excessive CXCL12-mediated downregulation of CXCR4 in migrating cortical interneurons.
Abe P; Mueller W; Schütz D; MacKay F; Thelen M; Zhang P; Stumm R
Development; 2014 May; 141(9):1857-63. PubMed ID: 24718993
[TBL] [Abstract][Full Text] [Related]
35. Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.
Luker KE; Lewin SA; Mihalko LA; Schmidt BT; Winkler JS; Coggins NL; Thomas DG; Luker GD
Oncogene; 2012 Nov; 31(45):4750-8. PubMed ID: 22266857
[TBL] [Abstract][Full Text] [Related]
36. CXCL12-CXCR4/CXCR7 axis contributes to cell motilities of oral squamous cell carcinoma.
Chen N; Jiang X; Wang J; Wu T; Cheng B; Xia J
Tumour Biol; 2016 Jan; 37(1):567-75. PubMed ID: 26232325
[TBL] [Abstract][Full Text] [Related]
37. CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis.
Roy I; Zimmerman NP; Mackinnon AC; Tsai S; Evans DB; Dwinell MB
PLoS One; 2014; 9(3):e90400. PubMed ID: 24594697
[TBL] [Abstract][Full Text] [Related]
38. CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer.
Zheng N; Liu W; Chen J; Li B; Liu J; Wang J; Gao Y; Shao J; Jia L
Mol Carcinog; 2019 Jan; 58(1):144-155. PubMed ID: 30259564
[TBL] [Abstract][Full Text] [Related]
39. Modulatory effects of trophoblast-secreted CXCL12 on the migration and invasion of human first-trimester decidual epithelial cells are mediated by CXCR4 rather than CXCR7.
Zheng J; Wang H; Zhou W
Reprod Biol Endocrinol; 2018 Mar; 16(1):17. PubMed ID: 29499763
[TBL] [Abstract][Full Text] [Related]
40. Critical involvement of atypical chemokine receptor CXCR7 in allergic airway inflammation.
Chang HC; Huang PH; Syu FS; Hsieh CH; Chang SL; Lu J; Chen HC
Immunology; 2018 Jun; 154(2):274-284. PubMed ID: 29250768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
